4
Changes in Ownership
FATE THERAPEUTICS INC Filed Acc 0000950170-24-008803
Chief Financial Officer sold 1,849 shares at $5.00 ($9,245)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dulac Edward J III Chief Financial Officer | 2024-01-29 | Sale 10b5-1 | −1,849 | $5.00 | $9,245 | 103,926 | D |
| Open-market sales · 1,849 sh · avg $5.00 · $9,245 | |||||||
Loading xslF345X05/ownership.xml…